Skip to content

Clinical trial to evaluate the efficacy of Ayurvedic Intervention in Shwitra with special reference to Vitiligo

Clinical Evaluation to Assess The Effocacy of Gunjaphaladi Lepa & Manibhdra Yoga In Shwitra With Special Reference to Vitiligo A Randomized Control Trial. - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100999
Enrollment
40
Registered
2026-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing to participate in the clinical trial. 2.Patients in the age group of 18 to 60 years of either sex. 3.Patient diagnosed as Shwitra (vitiligo) on the basis of clinical features mentioned in Ayurveda texts Twak vivarnaya, Rookshata, Romparidhwanshi, Kandu. 5.Patient who are in between 10%-75% range of VASI score will be selected. 6.Patient with history of Shwitra less than or equal to five years.

Exclusion criteria

Exclusion criteria: 1.Patient participated in any clinical trial within last six months. 2.White anesthetic spots, which are characteristic of leprosy. 3.Patches in genital area and over lips will be excluded from the study. 4.Vitiligo patches complicated with eczema, secondary bacterial infection. 5.Patients with evidence of malignancy, known case of uncontrolled diabetes mellitus, known case of uncontrolled hypertension , albinism and autoimmune disorders etc. 6.Pregnant women and lactating mother.

Design outcomes

Primary

MeasureTime frame
Assessment of changes in Vitiligo area & Scoring index (VASI score).Timepoint: baseline to the end of the trial period

Secondary

MeasureTime frame
Assessment of changes in clinical sign and symptoms. 1. Twak vivarnaya (colour of lesions) 2. Rookshata (dryness) 3. Romaparidhwanshi (hair fall) 4. Kandu (itching) Timepoint: baseline to the end of the trial period

Countries

India

Contacts

Public ContactDr Pravin Shamrao Sawant Sir

National Institute of Ayurveda,Deemed to be University

drsawantps@gmail.com9890275426

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026